JeenJo Kang

JeenJoo (JJ) Kang, PhD


Back to Team

Dr. JeenJoo (JJ) Kang serves as Chairwoman of Escient Pharmaceuticals. She is a Principal at The Column Group, a healthcare venture capital firm. She was the founding President of Tenaya Therapeutics and serves on its Board of Directors, and she also serves on the Board of Exonics Therapeutics. Previously, Dr. Kang worked at FibroGen in corporate strategy and in project management of drug discovery and development programs. Dr. Kang completed her doctorate in chemical biology at the California Institute of Technology in the laboratory of Professor Peter Dervan and obtained her undergraduate degree in chemistry from Harvard University.

Board of Directors: Tenaya Therapeutics, Exonics Therapeutics, Escient Pharmaceuticals